Activ8rlives Selected as Semi-Finalists for the CISCO British Innovation Gateway (BIG) Awards

HUNTINGDON, U.K. - July 13, 2015 - PRLog -- Aseptika today announced that they have been short-listed as one of twenty semi-finalists for the Cisco British Innovation Gateway (BIG) Awards (http://www.thebigawards.co.uk/), selected from over 150 entries from across the UK. The Cisco BIG Awards recognize industries experts based on their potential for accelerating marketable solutions centered on the Internet of Everything (IoE).

The competition is run in three phases, for which Aseptika has reached the second hurdle. Cisco (http://www.thebigawards.co.uk/about-the-competition/) is looking for ideas around the Internet of Things (IoT) and IoE specifically in the areas of application enablement, security and real time analytics, solving the challenges in sectors such as health.

Aseptika is a healthcare company developing and marketing an integrated suite of self-monitoring devices and services under the Activ8rlives (http://www.activ8rlives.com/) brand, which can be used by consumers and their healthcare service providers to better self-manage long-term health conditions (LTHC) through self-monitoring. The Company is presently working on two Generation #3 products with their vision having been formed through years of experience of working with both consumers and the NHS in healthcare.

- Ends –

About Aseptika Limited (Activ8rlives):

Aseptika Limited is a healthcare company developing and marketing an integrated suite of self-monitoring devices and services under the Activ8rlives brand. We are developing integrated systems which can be used by consumers and their healthcare service providers to better self-manage (http://www.activ8rlives.com/solutions/self-monitoring-and...) long-term health conditions (LTHC) through self-monitoring.

The Company’s goal is to provide everyone with tools (and the understanding of how to apply them) so that most of us can keep healthy and well for most of the time. Self-management through self-monitoring is the motivation driving what we do.

Activ8rlives is unusual in that we are device agnostic, incorporating sensors and monitors ranging from consumer accessories to in vitro diagnostics (IVDs) with a focus on respiratory disease. All data is held together and can be cross analysed in the Cloud to provide forecasts and learning for the user and clinician.

The Company gained a patent in 2013 protecting the invention of a test for biomarkers (http://www.activ8rlives.com/about/news-and-events/news/20...) of Pseudomonas aeruginosa (PA) in the sputum of patients, which can be used to detect the on-set of an exacerbation and profile the efficacy of antibiotic treatment for each patient.

Aseptika won first place in a competition earlier in 2014 to reward the most “Promising eHealth EU SME”eHealth solution 2014 (http://www.activ8rlives.com/about/news-and-events/news/2014/04/03/aseptika-wins-first-place-for-most-promising-ehealth-solution-competition-2014/#sthash.jm6jQb3Q.dpuf)developed by an early-stage European SME. The 2014 Competition was organized by TICBioMed and had the endorsement of the Health and Wellbeing Unit of DG CONNECT of the European Commission. The judges commended Aseptika for the integrated approach it was taking in the support of patients with long-term respiratory disease (http://www.activ8rlives.com/solutions/clinical-trials/), providing the platform to self-manage their illness through self-monitoring. Central to the Company’s “hospital-at-home” concept, is a test in which the patient measures the level of virulence of the bacteria living in their lungs which from time to time, flare into a full and repeated chest infections.

Aseptika was a shortlisted finalist for the Cambridge News Top Innovations 2014 (http://www.cambridge-news.co.uk/Innovations-2014/story-22802672-detail/story.html) and AXA PPP Health Tech & You (http://tr.axa-ppp.co.uk/do?B1D6C55B52E4CA5F29BAC297AFEC96616BEED2ADFC11507352CB0B093683219668A1A1FDC5BE1F9AAFCFBA515D62693465C0057B22D451DBCA5F71EBBA9990A9) Awards. Winner of the Discovery Start-up 2014 Competition (http://www.cambridgewireless.co.uk/news/article/default.aspx?objid=47697) run by Cambridge Wireless and Winner of the Hunts Post Huntingdonshire Business Innovation Awards 2014 (http://www.huntsbusinessawards.co.uk/). Named on Global Digital Health 100 Award (http://www.thejournalofmhealth.com/#!The-Journal-of-mHealth-Announces-the-2014-Global-Digital-Health-100-Recognising-the-Most-Innovative-Digital-Companies-in-Healthcare/cuhk/8C07B55F-084F-4C3E-BD3D-4A63343372FA) list, reflecting the importance of mobile and digital solutions.

Wearable Technology Awards 2015 (http://www.wearabletechnologyshow.net/awards) shortlisted Aseptika in three categories: Best Medical Device (placed third), Best Innovation and Overall Wearable Winner.

For more information on Aseptika Ltd, Activ8rlives and products, please visit: www.Activ8rlives.com

Activ8rlives, Activ8rlives.com, BuddyWOTCH and EyKos are trademarks of Aseptika Ltd.

For press information, please contact:

Jessica Auton, Marketing Director

jessica.auton@aseptika.com

Direct +44 (0)1480 352 821

Mobile +44 (0)7455 922 122